arthralgia incidence in trials is generally similar to placebo Rapid weight loss from GLP-1 treatment may alter biomechanical loading on joints, causing temporary adjustment-related discomfort Patients prescribed GLP-1 medications often have type 2 diabetes or obesity, conditions independently associated with increased osteoarthritis rates Seek medical advice for severe, worsening, or persistent joint pain, or if accompanied by swelling, redness, warmth, or systemic symptoms Report suspected medication side effects through the MHRA Yellow Card scheme to support ongoing safety monitoring Table of Contents Understanding GLP-1 Medications and Their Common Side Effects GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda), most commonly cause gastrointestinal side effects such as nausea, vomiting, and diarrhoea

Check out the paper and hats off for the tremendous work to Andrs Felipe Prez Palacios, Jorge Parra, Daniel Santiago Crdoba Velasco, Diana Carolina Zona Rubio, IZABEL ALMEIDA ALVES & Diana Marcela Aragon Novoa To view or add a comment, sign in #VNDA is a cash-rich small-cap biopharma trying to outrun a 2027 patent cliff, now with a newly approved motion-sickness drug and multiple near-term FDA catalysts
Impact of GLP-1 receptor agonists on psoriasis and cardiovascular comorbidities: a narrative review
(18)2026GLP-117GLP-1 (PwC Taiwan)GLP-1 GLP-1TLC518BioSeizer42027Q1(IND) FDFCDMOGLP-1CDMOsemaglutide (Siegfried Gschliesser)MIRA/JEANY-002ANY-004 semaglutideGLP-1 GLP-1 () GLP-1 CDMO (18)2026GLP-117GLP-1 (PwC Taiwan)GLP-1 GLP-1TLC518BioSeizer42027Q1(IND) FDFCDMOGLP-1CDMOsemaglutide (Siegfried Gschliesser)MIRA/JEANY-002ANY-004 semaglutideGLP-1 GLP-1 () (PwC Taiwan)GLP-1 GLP-1TLC518BioSeizer42027Q1(IND) FDFCDMOGLP-1CDMOsemaglutide (Siegfried Gschliesser)MIRA/JEANY-002ANY-004 semaglutideGLP-1 GLP-1 ()
S quay li nu dng hp
For some patients, bariatric surgery provides more effective, long lasting weight loss